GLP-1 drugs can be life-changing for people with obesity or diabetes
Patients with evidence of advanced fibrosis or cirrhosis should undergo evaluation by a hepatologist before starting weight loss injections
See the reconstitution guide in the Academy and use the calculator to convert your dose into exact units
The retatrutide triple agonist GLP-1 GIP glucagon mechanism works through three parallel axes: GLP-1 receptor activation: Stimulates glucose-dependent insulin secretion from pancreatic beta cells, suppresses glucagon release from alpha cells, slows gastric emptying, and reduces appetite signalling in the hypothalamus
Figure 1 from Colhoun , et al, Nat Med 2024 Even if semaglutide saves lives, hearts, and kidneys, and FLOW is a global trial, implementation of the so-called fourth pillar remains a local challenge
Next, stay for the diabetes tech show-and-tell as Diana demonstrates the specs of the latest pumps and sensors